Press Releases & News
Peptide Therapeutics Near the Sweetest Spots
Peptide therapeutics would seem to occupy a sweet spot between small molecules and biologics. Small molecules, which represent the majority of clinical drugs, preferentially bind hydrophobic pockets or cavities, [...]
Circle Pharma’s work with Pfizer yields new macrocyclic peptides
Circle Pharma Inc. said its first collaboration with Pfizer Inc. has led to the identification of a series of bioavailable macrocyclic peptides capable of acting as potent and cell-permeable modulators of CXCR7. [...]
Circle Pharma Announces Publication in Journal of Medicinal Chemistry of Results from Collaboration with Pfizer Inc.
Results from its collaborative work with Pfizer to develop a potent and orally bioavailable macrocycle modulator have been published [...]
Circle Pharma Announces Appointment of David Spellmeyer, PhD, as Chief Scientific Officer
David Spellmeyer, PhD, has been appointed as Circle Pharma's chief scientific officer [...]
Circle Pharma announces expansion of Series A financing and appointment of James C. Lu to its board
An expansion of Series A financing has been completed, with new investors W.I. Harper Group, [...]
Circle Pharma announces Series A financing and appoints Walter H. Moos, Ph.D., to its board
Series A financing round has been announced in which over $4.5M of shares have been issued [...]
Circle Pharma enters into an agreement with Pfizer to build screening library of macrocyclic peptides
Designing and creating a physical screening library of novel macrocyclicpeptides [...]
Circle Pharma Announces Appointment of Co-Founder Prof. Matthew Jacobson to Department Chair
Co-founder Prof. M. Jacobson has been appointed Chair of the UCSF Department of Pharm. Chemistry [...]
Circle Pharma Announces Receipt of Additional Seed Investment, and Relocation to New Laboratory Facility
The seed funding round has been extended with an investment from ShangPharma Investment Group [...]
Starting up and spinning out: The changing nature of partnerships between pharma and academia
In 2005, two chemists decided to work together to develop libraries of cyclic peptides that could be used to treat a range of infectious diseases, autoimmunity and cancer [...]
Full circle: Startup scores big deal with Pfizer — and QB3 is happy
Startup Circle Pharma Inc., a UCSF and UC Santa Cruz spinout devising ways to disrupt a wide variety of diseases from inside cells, will work with Pfizer Inc. on two drug programs [...]
Circle Pharma Announces Receipt of Seed Funding and Initiation of Two Collaborations
Circle Pharma has received seed funding from Pfizer Inc. and QB3’s seed-stage venture fund, Mission Bay Capital, LLC, and has initiated two collaborations with Pfizer [...]